Aller au contenu principal
Accès ouvert déclaré 2025 article

Impact of the initial administration of an antiretroviral drug with latency reversal properties on the HIV reservoir size

6Citations signalées — pas une note de qualité
43Institutions déclarées
2Pays d’affiliation déclarés

Résumé fourni par la source

The elimination of the latent viral reservoir remains the main barrier in the quest for a cure for people with HIV (PWH). The administration of latency reversal agents (LRA) at antiretroviral treatment (ART) initiation could improve the effectiveness of strategies aimed at HIV remission. This study assessed the impact of maraviroc (MVC), an antiretroviral drug with HIV latency reversal properties, on the viral reservoir size when it is administered at ART initiation. We conducted a longitudinal observational study in PWH initiating ART with a regimen including (MVC-initiation, n = 12) or not including MVC (non-MVC-initiation, n = 22), or switching to an MVC-containing regimen after achieving an undetectable viral load (VL) (MVC-switch, n = 9). The HIV reservoir size was determined via Alu-LTR and Intact Proviral DNA Assay (IPDA) methods, and cell-associated HIV-RNA (ca-HIV-RNA) by nested-qPCR. Comparative analyses employed mixed multivariate linear models. After a median of 90 weeks, the MVC-initiation group showed a greater reduction in integrated and IPDA-total (7.1- and 4.0-fold, respectively), but not IPDA-intact, HIV-DNA reservoir compared to the non-MVC-initiation group. The reductions in integrated, IPDA-total, and IPDA-intact HIV-DNA levels in the MVC-initiation group were also greater compared to the MVC-switch group (from 5.4 to 13.8-fold). Moreover, no significant differences in the HIV transcriptional activity, assessed by ca-HIV-RNA levels or HIV-RNA/HIV-DNA ratios, were observed between the MVC-initiation and non-MVC-initiation groups. In conclusion, starting ART with a drug with HIV latency reversing activity at detectable VL phase may contribute to a greater reduction in the HIV-DNA reservoir. These findings could inform the design of future trials targeting HIV remission via a "kick and kill" strategy.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Impact of the initial administration of an antiretroviral drug with latency reversal properties on the HIV reservoir size
Date Crossref
13/07/2025
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Instituto de Salud Carlos IIICentro de Investigación Biomédica en Red de Salud MentalCentro de Investigación Biomédica en RedInstituto Ramón y Cajal de Investigación SanitariaHospital Clínic de BarcelonaHospital Universitario de La PrincesaHospital Universitari Joan XXIII de TarragonaHealth Research Institute of the Balearic IslandsHospital Universitario Son EspasesSanta Lucía University General HospitalHospital Universitario Infanta SofíaInstituto de Biomedicina de SevillaCentro Nacional de MicrobiologiaCentro Nacional de EpidemiologíaInternational Olive CouncilUniversidad de AlcaláMadrid Health ServiceMútua TerrassaHospital Universitario 12 De OctubreInstituto de Investigación Biosanitaria de GranadaUniversity Hospital Complex Of VigoBiogipuzkoa Health Research InstituteHospital General Universitario de ElcheThe Coordinating CenterHospital General Universitario Gregorio MarañónHospital General Universitario de Alicante Doctor BalmisHospital Universitario de CanariasHospital Universitario Central de AsturiasHospital Reina Sofía de MurciaHospital Universitario Virgen de la ArrixacaComplexo Hospitalario Universitario A CoruñaHospital Universitari i Politècnic La FeHospital Universitario La PazHospital Universitario Ramón y CajalHospital Clínico Universitario Virgen de la VictoriaHospital Universitario Virgen del RocíoBellvitge University HospitalHospital Costa del SolHospital Universitario Príncipe de AsturiasHospital Clínico Universitario de ValenciaHospital Universitario Reina SofíaHospital Universitario Severo OchoaHospital Universitario de Valme

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

HIV Research and TreatmentHIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.